Pradax (dabigatran etexilate) to compete with warfarin and heparins

Canada is leading the pack in North America by approving Pradax (dabigatran etexilate) to compete with warfarin and heparins....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login